Abbott Laboratories (ABT) News Today → Are You Positioned For The New Energy Goldrush? (From Wealthpin Pro) (Ad) Free ABT Stock Alerts $102.19 +0.45 (+0.44%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 1 at 2:09 PM | marketbeat.comBank of Nova Scotia Has $39.04 Million Stake in Abbott Laboratories (NYSE:ABT)Bank of Nova Scotia boosted its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 90.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 354,702 shares of the healthcare product maker's stock after purMay 30 at 6:39 PM | marketbeat.comTFO Wealth Partners LLC Buys 8,142 Shares of Abbott Laboratories (NYSE:ABT)TFO Wealth Partners LLC boosted its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 2,035.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 8,542 shares of the healthcare product maker's stock afMay 30 at 4:08 PM | gurufocus.comUnlocking Intrinsic Value: Analysis of Abbott LaboratoriesMay 30 at 8:16 AM | americanbankingnews.comThe Goldman Sachs Group Initiates Coverage on Abbott Laboratories (NYSE:ABT)May 30 at 8:15 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Earns Buy Rating from Analysts at The Goldman Sachs GroupThe Goldman Sachs Group initiated coverage on Abbott Laboratories in a report on Thursday. They issued a "buy" rating and a $121.00 price objective on the stock.May 29 at 4:50 PM | msn.comGreg Abbott Gets New Ally in TexasMay 29 at 4:50 PM | msn.comAbbott sees path for school voucher victory after Texas House runoffsMay 29 at 11:45 AM | marketbeat.comTD Asset Management Inc Has $145.49 Million Stake in Abbott Laboratories (NYSE:ABT)TD Asset Management Inc reduced its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 36.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,321,757 shares of the healthcare productMay 29 at 12:50 AM | marketbeat.comAbbott Laboratories (NYSE:ABT) Position Lessened by Bruce & Co. Inc.Bruce & Co. Inc. reduced its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 6.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 150,000 shares of the healthcare product maker's stock after sellingMay 29 at 12:28 AM | msn.comTyler James Williams Admits To “Lying” About His ‘Abbott Elementary’ Romantic Arc In Past InterviewsMay 29 at 12:28 AM | msn.comSchool voucher supporters backed by Abbott lead in pivotal Texas House GOP runoffsMay 28, 2024 | msn.comSir Keir Starmer in new row over Diane Abbott suspensionMay 28, 2024 | msn.comAbbott Labour race row investigation completedMay 28, 2024 | msn.comTexas House runoff elections could seal revenge wins for Paxton, AbbottMay 28, 2024 | investorplace.comWall Street Favorites: 3 Healthcare Stocks With Strong Buy Ratings for May 2024May 27, 2024 | foxnews.comTexas state senator criticizes Abbott as 'piece of s--t' for not publicly mentioning Uvalde shootingMay 27, 2024 | msn.comGreg Abbott Faces New Republican TestMay 27, 2024 | newsweek.comTexas Democrat Praises Greg Abbott Amid New Border Wall ConstructionMay 27, 2024 | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Bought by United Services Automobile AssociationUnited Services Automobile Association increased its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 110.4% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 97,678 shares of the healthcare product maker's stocMay 27, 2024 | investorplace.comReliable Rewards: 7 Dividend Stocks to Count On in Any MarketMay 27, 2024 | investorplace.comBlue-Chip Bonanza: 3 Stocks to Ride the Market's Coattails to RichesMay 25, 2024 | marketbeat.comTCW Group Inc. Acquires New Stake in Abbott Laboratories (NYSE:ABT)TCW Group Inc. bought a new stake in Abbott Laboratories (NYSE:ABT - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The fund bought 28,267 shares of the healthcare product maker's stock, valued at approximately $3,120,000. Several other hedge funds have alsoMay 25, 2024 | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Sold by Primecap Management Co. CAPrimecap Management Co. CA lessened its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 2.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,858,141 shares of the healthMay 23, 2024 | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Bought by Cambridge Investment Research Advisors Inc.Cambridge Investment Research Advisors Inc. boosted its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 8.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 299,242 shares of the healtMay 23, 2024 | americanbankingnews.comAbbott Laboratories (NYSE:ABT) Price Target Cut to $119.00May 22, 2024 | markets.businessinsider.comCritical Insights From Abbott Laboratories Analyst Ratings: What You Need To KnowMay 22, 2024 | marketbeat.comFrazier Financial Advisors LLC Takes $3.68 Million Position in Abbott Laboratories (NYSE:ABT)Frazier Financial Advisors LLC acquired a new stake in Abbott Laboratories (NYSE:ABT - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 33,414 shares of the healthcare product maker'sMay 21, 2024 | marketbeat.comOxler Private Wealth LLC Buys 10,454 Shares of Abbott Laboratories (NYSE:ABT)Oxler Private Wealth LLC lifted its position in Abbott Laboratories (NYSE:ABT - Free Report) by 141.3% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 17,851 shares of the healthcare product maker's stockMay 20, 2024 | marketbeat.comAbbott Laboratories (NYSE:ABT) Stock Holdings Increased by Franklin Resources Inc.Franklin Resources Inc. raised its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 1.6% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 8,316,700 shares of the healthcare product maker's stock after buying an additional 1May 20, 2024 | markets.businessinsider.comBuy Rating Affirmed for Abbott Laboratories Based on Strong EP Business and Strategic Growth ProspectsMay 19, 2024 | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Sold by ING Groep NVING Groep NV cut its holdings in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 71.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 272,681 shares of the healthcare product maker's stockMay 18, 2024 | marketbeat.comAbbott Laboratories (NYSE:ABT) is Great Lakes Advisors LLC's 7th Largest PositionGreat Lakes Advisors LLC lowered its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 14.8% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,121,309 shares of the healthcare product maker's stock after sellingMay 17, 2024 | marketbeat.comFairhaven Wealth Management LLC Acquires 10,495 Shares of Abbott Laboratories (NYSE:ABT)Fairhaven Wealth Management LLC grew its holdings in Abbott Laboratories (NYSE:ABT - Free Report) by 196.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 15,834 shares of the healthcare product maker'sMay 17, 2024 | finance.yahoo.comAbbott (ABT) Down 0.4% Since Last Earnings Report: Can It Rebound?May 16, 2024 | markets.businessinsider.comBuy Recommendation for Abbott Laboratories Backed by Strong Sales Growth and Promising PipelineMay 16, 2024 | fool.comThese Dividend Stocks Are an Investor's Best FriendMay 15, 2024 | marketbeat.comLmcg Investments LLC Boosts Position in Abbott Laboratories (NYSE:ABT)Lmcg Investments LLC lifted its position in Abbott Laboratories (NYSE:ABT - Free Report) by 15.5% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 149,847 shares of the healthcare prMay 15, 2024 | insidertrades.comAbbott Laboratories (NYSE:ABT) EVP Jr. Robert E. Funck Sells 10,097 SharesMay 14, 2024 | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Sold by Curi Wealth Management LLCCuri Wealth Management LLC reduced its stake in Abbott Laboratories (NYSE:ABT - Free Report) by 12.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 59,283 shares of the healthcare product maker's stock aftMay 14, 2024 | marketbeat.comInsider Selling: Abbott Laboratories (NYSE:ABT) EVP Sells 10,097 Shares of StockAbbott Laboratories (NYSE:ABT - Get Free Report) EVP Jr. Robert E. Funck sold 10,097 shares of the business's stock in a transaction on Friday, May 10th. The stock was sold at an average price of $104.57, for a total transaction of $1,055,843.29. Following the transaction, the executive vice president now directly owns 211,341 shares of the company's stock, valued at approximately $22,099,928.37. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.May 13, 2024 | marketbeat.comPrincipal Financial Group Inc. Sells 120,988 Shares of Abbott Laboratories (NYSE:ABT)Principal Financial Group Inc. reduced its position in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 2.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,743,910 shares of the healthcare prMay 12, 2024 | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Sold by Massachusetts Financial Services Co. MAMassachusetts Financial Services Co. MA reduced its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 11.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 12,053,028 shares of the healthcare product mMay 11, 2024 | marketbeat.comAbbott Laboratories (NYSE:ABT) Shares Bought by Dimensional Fund Advisors LPDimensional Fund Advisors LP raised its stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) by 24.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,226,618 shares of the healthcare productMay 11, 2024 | 247wallst.comJP Morgan Has 5 Blue Chip Passive Income Stocks as Top Picks for MayMay 11, 2024 | marketbeat.comPrincipal Securities Inc. Takes $2.93 Million Position in Abbott Laboratories (NYSE:ABT)Principal Securities Inc. bought a new stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 26,639 shares of the healthcare product maker's stock, valMay 10, 2024 | insidertrades.comLisa D. Earnhardt Sells 22,852 Shares of Abbott Laboratories (NYSE:ABT) StockMay 9, 2024 | marketbeat.comBreed s Hill Capital LLC Invests $895,000 in Abbott Laboratories (NYSE:ABT)Breed s Hill Capital LLC bought a new stake in shares of Abbott Laboratories (NYSE:ABT - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 8,131 shares of the healthcare product maker's stock,May 9, 2024 | reuters.comDrugmaker Abbott India posts Q4 profit rise on higher salesMay 9, 2024 | marketbeat.comAbbott Laboratories (NYSE:ABT) Receives Consensus Rating of "Moderate Buy" from AnalystsAbbott Laboratories (NYSE:ABT - Get Free Report) has earned an average recommendation of "Moderate Buy" from the nine brokerages that are currently covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a hold recommendation and six have assigned a buy recommendMay 9, 2024 | finance.yahoo.comInsider Sale: Executive Vice President Lisa Earnhardt Sells 22,852 Shares of Abbott ... Get Abbott Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter. Email Address On June 10, Nvidia makes its next big move (Ad)A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.” Click here to find out who they are. ABT Media Mentions By Week ABT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ABT News Sentiment▼0.480.79▲Average Medical News Sentiment ABT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ABT Articles This Week▼2317▲ABT Articles Average Week Get Abbott Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ISRG News SYK News BSX News MDT News BDX News EW News DXCM News IDXX News BIIB News RMD News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:ABT) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaDems have chosen Biden replacement?Paradigm PressClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceNvidia is about to pass AppleWeiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abbott Laboratories Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
